|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.089 AUD | +3.49% |
|
-4.30% | -38.62% |
| Apr. 17 | Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant | MT |
| Apr. 17 | Ord Minnett Starts ImpediMed at Speculative Buy, Price Target is AU$0.16 | MT |
ImpediMed Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported revenue was AUD 11.34 million compared to AUD 10.56 million a year ago. Net loss was AUD 20.52 million compared to AUD 19.87 million a year ago.
Basic loss per share from continuing operations was AUD 0.01 compared to AUD 0.01 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -38.62% | 113M | |
| +8.77% | 219B | |
| +6.83% | 183B | |
| +10.65% | 133B | |
| +24.59% | 108B | |
| +0.27% | 63.06B | |
| +12.40% | 52.02B | |
| +3.96% | 48.2B | |
| +0.15% | 40.37B | |
| +14.23% | 39.35B |
IMPEDIMED LIMITED 
